Phibro Animal Health | Ativo Circulante



Current Assets Alterar Data
Align Technology USD 2.4B 90.41M 2025-03
ANI Pharmaceuticals USD 536.29M 8.61M 2025-03
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 438.5M 33.1M 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Henry Schein USD 4.04B 54M 2025-03
Idexx Laboratories USD 1.32B 82.28M 2025-03
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Merck USD 35.5B 3.28B 2025-03
Pacira USD 759.96M 14.83M 2025-03
Prestige Brands USD 448.33M 71.16M 2025-03
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Zoetis USD 5.88B 109M 2025-03



Phibro Animal Health Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.